Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals

Completed

Conditions studied: Influenza, Human, Human Immunodeficiency Virus I Infection

In brief

Investigators in the Division of Infectious Diseases are carrying out a study to determine if human immunodeficiency virus (HIV)-seropositive patients receiving the Seasonal Influenza vaccination develop an adequate antibody response. The study group will consist of individuals seen in the Infectious Diseases Clinic who are HIV-seropositive and receive the Seasonal Influenza vaccine.

Key facts

Study ID

NCT01381029

Run by

George Washington University

People needed

74

Starts

2009-09-01

Expected to finish

2014-08-01

Last updated by the study team

2023-05-19

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or female patients ages 18 or older
• Diagnosis of HIV infection
• No contraindications to being able to receive influenza vaccine by the treating physician
• No acute active illness
• Able to provide informed consent

You may not qualify if…

• Previous history of hypersensitivity reaction to influenza vaccine
• Unable to return for follow-up blood draw

Where it is running

• Medical Faculty Associates — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.